ADMA Biologics ADMA Payments Of Debt Issuance Cost
Payments Of Debt Issuance Cost at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept adma:PaymentsOfDebtIssuanceCost.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's payments of debt issuance cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's payments of debt issuance cost?
- ADMA Biologics (ADMA) reported payments of debt issuance cost of $559.25K in Q4 2025.
- What does payments of debt issuance cost mean?
- Direct cash expenditures, such as legal, accounting, and underwriting fees, incurred to issue new debt. These costs are capitalized and amortized over the life of the debt, and tracking them provides visibility into the cost of capital acquisition.